Metrikler
Yayın
73
Açık Erişim
13
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1999 - 2006
1999 - 2006Doktora
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Türkiye
1991 - 1994
1991 - 1994Yüksek Lisans
İstanbul Üniversitesi, Fen Fakültesi, Biyoloji Bölümü, Türkiye
1985 - 1991
1985 - 1991Lisans
İstanbul Üniversitesi, Fen Fakültesi, Biyoloji Bölümü, Türkiye
Araştırma Alanları
Sağlık Bilimleri
Temel Bilimler
Akademik Ünvanlar / Görevler
2009 - Devam Ediyor
2009 - Devam EdiyorDr. Öğr. Üyesi
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
2007 - 2009
2007 - 2009Yrd. Doç. Dr.
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
1996 - 2006
1996 - 2006Araştırma Görevlisi
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
Makaleler
Tümü (8)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (4)
Scopus (7)
TRDizin (1)
Diğer Yayınlar (1)
2023
20231. Combination therapy with chitosan/siRNA nanoplexes targeting PDGF-D and PDGFR-β reveals anticancer effect in breast cancer
Şalva E., Özbaş S., Alan S., Özkan N., Ekentok-Atıcı C., Kabasakal L., et al.
Journal of Gene Medicine
, cilt.25, sa.2, 2023 (SCI-Expanded)
2020
20202. Mesenchymal stem cell therapy improves erectile dysfunction in experimental spinal cord injury
Albayrak Ö., Şener T. E., Erşahin M., Özbaş-Turan S., Ekentok C., Tavukçu H., et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
, cilt.32, sa.3, ss.308-316, 2020 (SCI-Expanded)
2016
20163. Non viral siRNA and shRNA delivery systems in cancer therapy
ŞALVA E., EKENTOK C., ÖZBAŞ S., AKBUĞA F. J.
RNA interference , ss.201-202, 2016 (Hakemli Dergi)
2012
20124. Synthesis and evaluation of cytotoxic activities of some 1,4-disubstituted thiosemicarbazides, 2,5-disubstituted-1,3,4- thiadiazoles and 1,2,4-triazole-5-thiones derived from benzilic acid hydrazide Benzilik asid hidrazidinden elde edilen bazı 1,4-disübstitüe tiyosemikarbazidler, 2,5-disübstitüe-1,3,4-tiyadiazoller ve 1,2,4-triazol-5-tiyonların sentezi ve sitotoksik aktivitelerinin deǧerlendirilmesi
Çoruh I., Rollas S., Turan S., Akbuǧa J.
Marmara Pharmaceutical Journal
, cilt.16, sa.1, ss.56-63, 2012 (Scopus)
2011
20115. Synthesis and evaluation of cytotoxic activities of some substituted isoxazolone derivatives Sübstitüe izoksazolon türevlerinin sentezi ve sitotoksik aktivitelerinin deǧerlendirilmesi
Rollas S., Kokyan Ş., Koçyiǧit-Kaymakçioǧlu B., Özbaş-Turan S., Akbuǧa J.
Marmara Pharmaceutical Journal
, cilt.15, sa.3, ss.94-99, 2011 (Scopus)
2003
20036. Transfection efficiency of chitosan microspheres: Effect of DNA topology
Akbuga J., Aral C., Özbas-Turan S., Kabasakal L., Keyer-Uysal M.
S.T.P. Pharma Sciences
, cilt.13, sa.2, ss.99-103, 2003 (SCI-Expanded)
2000
20007. Studies of effective factors of plasmid DNA-loaded chitosan microspheres I. Plasmid size, chitosan concentration and plasmid addition techniques
Aral C., Özbas-Turan S., KABASAKAL L., Keyer-Uysal M., Akbuga J.
S.T.P. Pharma Sciences
, cilt.10, sa.1, ss.83-88, 2000 (SCI-Expanded)
1999
19998. Co-encapsulation of double plasmids in chitosan microspheres as a non-viral gene delivery vehicle
Ozbas-Turan S., Aral C., KABASAKAL L., Keyer-Uysal M., Akbuga J.
Proceedings of the Controlled Release Society
, sa.26, ss.645-646, 1999 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2022
20221. Sodium alginate-Chitosan Hydrogels for Gene Delivery
CÖMEZ B., ÖZBAŞ S.
20th International Pharmaceutical Technology Symposium, Türkiye, 21 - 23 Şubat 2022, (Tam Metin Bildiri)
2021
20212. The cellular uptake and endosomal escape mechanisms of chitosan-protamine-siRNA nanoplexes for efficient gene transfection and silencing
ŞALVA E., EKENTOK C., CÖMEZ B., ÖZBAŞ S., AKBUĞA F. J.
BioTürkiye International Biotechnology Congress, İstanbul, Türkiye, 9 - 11 Eylül 2021, (Özet Bildiri)
2019
20193. Investıgatıon Of Antıneoplastıc Actıvıty Of Achıllea Nobılıs Subsp. Neılreıchıı Plant In Experımental Breast Cancer.
Sehlan S. S., HAZAR YAVUZ A. N., EKENTOK C., TAŞKIN T., ALAN S., ÖZBAŞ TURAN S., et al.
International multidiciplinary symposium on drug research development. 01-03 June 2019, Malatya-Turkey, 01 Temmuz 2019, (Özet Bildiri)
2019
20194. Selection of mammaglobin aptamerselectıon for targeting breast cancer treatment
İpek T. Ç., ŞALVA E., Adalı M. A., ÖZBAŞ S.
İnternational multidisciplinary symposium on drug research development, Malatya, Türkiye, 1 - 03 Temmuz 2019, (Tam Metin Bildiri)
2018
20185. In vitro studies on inhibition of mammaglobin gene expression with chitosan/shRNAnanoplexes in breast cancer cell lines
ÖZBAŞ TURAN S., ŞALVA E., EKENTOK C., ÖZKAN A.
International IVEC BIO Congress, 26 - 28 Kasım 2018, (Özet Bildiri)
2018
20186. In Vitro Studies on Inhibition of Chitosan / siRNA Nanoplexes and Mammaglobin GeneExpression in Breast Cancer Cell Lines
ÖZBAŞ TURAN S., ŞALVA E., EKENTOK C., ÖZKAVAK Ş. B.
International IVEC BIO Congress, 26 - 28 Kasım 2018, (Özet Bildiri)
2016
20167. The silencing of PDGF B pathway by Chitosan siRNA nanoplexes in therapy of the experimental mesangial proliferative glomerulonephritis
ŞALVA E., ALAN S., YILMAZ İ., TURAN S., AKBUĞA F. J.
ESGCT XXIVth Annual Congress “Changing The Face of Modern Medicine: Stem Cells and Gene Therapy”, 18 - 21 Ekim 2016, (Özet Bildiri)
2016
20168. The investigation of effects to cell proliferation and adsorption of new ternary and binary scaffolds
SİRKECİ A., ŞALVA E., TURAN S., AKBUĞA F. J.
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, 18 - 21 Ekim 2016, (Özet Bildiri)
2016
20169. Tumor Inhibition by Using Chitosan: siRNA PDGFR-beta in Breast Cancer Model of Rat
Akbuga J., Turan S., ŞALVA E., ÖZKAN N., KABASAKAL L., Alan S.
19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Washington, Kiribati, 4 - 07 Mayıs 2016, cilt.24, (Özet Bildiri)
2015
201510. The in vitro Investigation of PAI 1 Containing Chitosan Nanoplexes in Hepatocellular Carcinoma
AKBUĞA F. J., NAZİKTER BETÜL B., AĞIRBAŞLI M. A., ŞALVA E., TURAN S.
XV th International Workshop Molecular and Cellular Biologyof Plasminogen Activation, 22 - 26 Eylül 2015, (Özet Bildiri)
2015
201511. Synthesis cytotoxic and antiproliferative activity of sulphanylamide substituted urea derivatives
TÜRK S., KARAKUŞ S., TURAN S., AKBUĞA F. J.
ISOPS 11th International Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015, (Özet Bildiri)
2015
201512. PDGF-D Inhibition by Using Chitosan: siRNA Complexes in Breast Cancer Model of Rat
Akbuga J., ÖZBAŞ TURAN S., KABASAKAL L., Salva E., ÖZKAN N.
18th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Louisiana, Amerika Birleşik Devletleri, 13 - 16 Mayıs 2015, cilt.23, (Özet Bildiri)
2015
201513. The Silencing by Chitosan PDGF B Nanoplexes of Mesangial Cell Proliferation in Renal Disease
ŞALVA E., TURAN S., ALAN S., AKBUĞA F. J.
XXI. Annual Meeting German Society for Gene Therapy, Vienna, Avusturya, 26 - 28 Şubat 2015, ss.84-85, (Özet Bildiri)
2014
201414. Investigation of gene silencing effect of chitosan nanoparticles containing shRNA PDGF-D in breast cancer cell lines
Akbuga J., ÖZBAŞ TURAN S., EKENTOK ATICI C.
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
2013
201315. Co-Delivery of VEGF siRNA and IL-4 into Chitosan Nanoparticles in Breast Tumor Model of Rat
ŞALVA E., ÖZBAŞ TURAN S., KABASAKAL L., EREN F., Alan S., ÖZKAN N., et al.
16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Utah, Amerika Birleşik Devletleri, 15 - 18 Mayıs 2013, cilt.21, (Özet Bildiri)
2012
201216. Discovery of a potent apoptosis inducer in K 562 cancer cell line
MEGA TİBER P., ORUN O., Aydın S., TURAN S., AKBUĞA F. J., KÜÇÜKGÜZEL Ş. G.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2012, ss.345
2011
201117. Synthesıs Biological Activitiy of Hydrazide Hydrazones And 4 Thiazolidinones Derived From Etodolac
ÇIKLA SÜZGÜN P., ÖZSAVCI D., BİNGÖL ÖZAKPINAR Ö., ÇEVİK Ö., ŞENER A., TURAN S., et al.
International Science & Technolocy Conference ISTEC, 7 - 09 Aralık 2011, (Tam Metin Bildiri)
2010
201018. Synthesis and cytotoxic activity of some new substituted 4(3H)-quinazolinone derivatives
URAZ M., KARAKUŞ S., TURAN S., AKBUĞA J.
IMMPC-ISPC JOINT MEETING, Ankara, Türkiye, 30 Eylül - 02 Ekim 2010, (Özet Bildiri)
2010
201019. Chitosan nanoparticles containing shRNA targeting VEGF as cancer therapeutic
Salva E., Ozbas-Turan S., Akbuga J.
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1412-1413, (Özet Bildiri)
2010
201020. Intramuscular Delivery of Antisense Oligonucleotides by Chitosan Nanoparticles
Ozbas-Turan S., Akbuga J., Sezer A. D., Salva E.
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1452-1453, (Özet Bildiri)
2008
200821. Topical delivery of antisense oligonucleotide using chitosan nanoparticles
ÖZBAŞ TURAN S., Akbuga J., SEZER A. D.
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1167, (Özet Bildiri)
Kitaplar
2011
20111. Chitosan of nanoparticles containing siRNA targeting VEGF for anti-angiogenic gene therapy
ŞALVA E., TURAN S., AKBUĞA F. J.
Advances in Chitin Science Vol XIII, Velery Varlamov, Svetlana Bratskaya, Irina Yakovleva, Sevda Senel, Editör, Euchis, ss.248-252, 2011
Patent